PharmacoEconomics and Outcomes News

NHS audits reveal coding errors of £1 billion
pp. 2-2(1)

Counterfeit drugs a growing problem
pp. 2-2(1)

Supply of influenza vaccine insufficient in China
pp. 2-2(1)

NICE has provisionally recommended thalidomide and bortezomib for the treatment of multiple myeloma.
pp. 2-2(1)

No final guidance yet for bevacizumab from NICE
pp. 3-3(1)

The costs of "old age" need redefining
pp. 3-3(1)

Lack of palliative pain relief for children in Kenya
pp. 3-3(1)

Media coverage on ADRs may do more harm than good
pp. 3-3(1)

EULAR has made recommendations for the monitoring of adverse events of low-dose glucocorticoid therapy in both clinical trials and daily practice.
pp. 3-3(1)

Greece begins drug price cuts
pp. 4-4(1)

US guidelines for treating complications of CF released
pp. 4-4(1)

Pharmac and Roche deal should save costs
pp. 4-4(1)

The market for liver cancer drugs in China is expected to grow from $US53 million in 2009 to $144 million in 2014
pp. 4-4(1)

Safety guidance spurs new insulin pen release in the UK
pp. 4-4(1)

Botulinum toxin A cost effective for urinary incontinence in France . . .
pp. 5-5(1)

Adherence to oral antidiabetic drugs reduces costs
pp. 5-5(1)

Cost effective diagnosis of COPD
pp. 5-5(1)

News from ICTS
pp. 6-7(2)

ADA-recommended interventions for diabetes control reviewed
pp. 7-7(1)

Ranibizumab appears worthwhile for AMD in Germany
pp. 7-7(1)

Telehealth cost effective in some scenarios
pp. 8-8(1)

Alarming rise in antipsychotic prescribing after Italian quake
pp. 8-8(1)

Most cost effective antidepressant treatment in a Spanish setting?
pp. 8-8(1)

Colorectal cancer screening a "cost-effective measure" in Canada
pp. 8-8(1)

RCTs rarely mention drug costs
pp. 9-9(1)

Preventative migraine treatments cost effective
pp. 9-9(1)

Lidocaine-medicated plaster a cost-effective option for PHN
pp. 9-9(1)

Trabectedin "potentially cost-effective" for soft tissue sarcoma
pp. 9-9(1)

Most cost effective maintenance therapy for bipolar I disorder?
pp. 10-10(1)

Unclear if policy change prevented further fentanyl deaths
pp. 10-10(1)

Rural telemedicine for depression "effective but expensive"
pp. 10-10(1)

"Clear correlation" found between opioid side effects and QOL
pp. 11-11(1)

CT colonoscopy costs "too high"
pp. 11-11(1)

Cost savings by preventing HIV
pp. 11-11(1)

Low-dose naltrexone improves QOL in MS
pp. 11-11(1)